NKGen Biotech, Inc.
Key Highlights
- NKGen Biotech is pioneering the use of super-activated NK cell therapies, which have the potential to revolutionize the treatment of neurodegenerative and oncological diseases.
- The company's proprietary SNK platform is a key differentiator, enabling the development of highly effective and personalized cell therapies.
- NKGen Biotech's mission-driven approach focuses on improving patient outcomes through innovative and natural treatment options.
- The company's commitment to advancing the field of immune cell therapeutics positions it as a leader in the biotechnology industry.
- NKGen Biotech's strategic focus on both autologous and allogeneic therapies allows for a broad range of treatment options, catering to diverse patient needs.
About NKGen Biotech, Inc.
NKGen Biotech, Inc. is a clinical-stage biotechnology company based in Santa Ana, California, founded in 2017. The company specializes in developing and commercializing innovative natural killer (NK) cell therapies to treat neurodegenerative and oncological diseases. Utilizing its proprietary SNK (super-activated) platform, NKGen Biotech aims to harness the body's immune system through autologous, allogeneic, and CAR-NK cell therapies. The company's mission is to improve patients' lives in a safe and natural way, with a vision to become the global leader in immune cell therapeutics.
NKGen Biotech's approach focuses on leveraging the body's natural defenses to combat diseases, offering a potentially transformative treatment option for patients with limited alternatives. The company's innovative therapies are designed to be both effective and accessible, with a commitment to advancing the field of cell therapy.
For more information, visit NKGen Biotech's website at www.nkgenbiotech.com.
Leadership Team
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
Company Facts
| Ownership Public Company |
| Stock NKGN (OTC) |
| Funding $11M |
Technology Stack
- SNK (super-activated) platform
Why Contact NKGen Biotech, Inc.?
B2B professionals should contact NKGen Biotech, Inc. for opportunities in innovative cell therapy products and partnerships that can advance the field of immune cell therapeutics. Their cutting-edge technologies and commitment to patient care make them an attractive partner for companies seeking to expand their offerings in the biotechnology sector.
Who Should Contact NKGen Biotech, Inc. for Business?
Sales teams selling biotechnology products, recruiters seeking roles in clinical-stage research, and partners offering services in the field of immune cell therapeutics should reach out to NKGen Biotech, Inc.
Categories
- NK cell therapies
- cell therapy
- immune cell therapeutics
- SNK platform
- autologous therapies
- allogeneic therapies
- CAR-NK
- neurodegenerative diseases
- oncological diseases
- clinical-stage biotechnology
Similar Companies
Companies that compete with or operate in similar markets to NKGen Biotech, Inc.:
- Jazz Pharmaceuticals
More Biotechnology Companies
Frequently Asked Questions
- Who is the CEO of NKGen Biotech, Inc.?
- The Chairman and Chief Executive Officer of NKGen Biotech is Paul Y. Song, M.D.
- What does NKGen Biotech, Inc. do?
- NKGen Biotech is a clinical-stage biotechnology company that develops and commercializes innovative autologous and allogeneic natural killer (NK) cell therapeutics to treat neurodegenerative and oncological diseases using its proprietary SNK platform.
- How many employees does NKGen Biotech, Inc. have?
- NKGen Biotech, Inc. has approximately 54 employees.
- Where is NKGen Biotech, Inc. headquartered?
- The company is headquartered in Santa Ana, California, United States.
- What industry is NKGen Biotech, Inc. in?
- NKGen Biotech, Inc. operates in Biotechnology, Cell Therapy, Immune Cell Therapeutics.
- When was NKGen Biotech, Inc. founded?
- NKGen Biotech, Inc. was founded in 2017.
- Is NKGen Biotech, Inc. still active?
- Yes, NKGen Biotech, Inc. was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
- How do I sell to NKGen Biotech, Inc.?
- Research NKGen Biotech, Inc.'s priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.
Ready to Sell to NKGen Biotech, Inc.?
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Backed by startup programs from
Connect with NKGen Biotech, Inc.